AT387576B - Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate - Google Patents

Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate

Info

Publication number
AT387576B
AT387576B AT0339884A AT339884A AT387576B AT 387576 B AT387576 B AT 387576B AT 0339884 A AT0339884 A AT 0339884A AT 339884 A AT339884 A AT 339884A AT 387576 B AT387576 B AT 387576B
Authority
AT
Austria
Prior art keywords
oxazino
producing new
isochinoline derivatives
isochinoline
derivatives
Prior art date
Application number
AT0339884A
Other languages
English (en)
Other versions
ATA339884A (de
Inventor
Gabor Dr Bernath
Jenoe Dr Kobor
Ferenc Dr Fueloep
Pal Dipl Chem Ing Dr Sohar
Pal Dr Perjesi
Elemer Ezer
Gyoergy Dr Hajos
Eva Dr Palosi
Laszlo Dr Denes
Laszlo Dr Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA339884A publication Critical patent/ATA339884A/de
Application granted granted Critical
Publication of AT387576B publication Critical patent/AT387576B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT0339884A 1983-10-25 1984-10-25 Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate AT387576B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU833654A HU190458B (en) 1983-10-25 1983-10-25 Process for preparing /1,3/ oxazino /4,3-a/ isoquinoline-derivatives

Publications (2)

Publication Number Publication Date
ATA339884A ATA339884A (de) 1988-07-15
AT387576B true AT387576B (de) 1989-02-10

Family

ID=10964931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0339884A AT387576B (de) 1983-10-25 1984-10-25 Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate

Country Status (15)

Country Link
US (1) US4623647A (de)
JP (1) JPS60115589A (de)
AT (1) AT387576B (de)
BE (1) BE900883A (de)
CA (1) CA1238905A (de)
CH (1) CH664570A5 (de)
DE (1) DE3439131A1 (de)
DK (1) DK508684A (de)
FI (1) FI76806C (de)
FR (1) FR2553776B1 (de)
GB (1) GB2148887B (de)
HU (1) HU190458B (de)
IT (1) IT1213235B (de)
NL (1) NL8403251A (de)
SE (1) SE462043B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191301B (en) * 1984-03-23 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing 1-/hydroxy-methyl/-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- or -thiazino/4,3-a/isoquinoline -derivatives
KR100429356B1 (ko) * 2001-04-23 2004-05-31 조수동 다약제 내성 극복 이소퀴놀린계 화합물 및 그 제조방법
US7264709B2 (en) * 2004-09-21 2007-09-04 Siemens Water Technologies Holding Corp. Method and apparatus for conditioning a sensor for measuring oxidation reduction potential

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421063A (en) * 1972-02-14 1976-01-14 Ayerst Mckenna & Harrison Fused-ring indole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094470A (en) * 1965-08-19 1967-12-13 Merck Ag E Isoquinoline derivatives and preparation thereof
US3389141A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-aryloxyethyltetrahydro-isoquinolines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421063A (en) * 1972-02-14 1976-01-14 Ayerst Mckenna & Harrison Fused-ring indole derivatives

Also Published As

Publication number Publication date
FI844187A0 (fi) 1984-10-25
CA1238905A (en) 1988-07-05
SE462043B (sv) 1990-04-30
US4623647A (en) 1986-11-18
IT1213235B (it) 1989-12-14
FR2553776A1 (fr) 1985-04-26
CH664570A5 (de) 1988-03-15
GB8425250D0 (en) 1984-11-14
FI844187L (fi) 1985-04-26
DK508684D0 (da) 1984-10-25
SE8405338A (sv) 1985-04-26
GB2148887B (en) 1987-02-25
FI76806B (fi) 1988-08-31
BE900883A (fr) 1985-04-24
FR2553776B1 (fr) 1987-04-24
ATA339884A (de) 1988-07-15
JPS60115589A (ja) 1985-06-22
NL8403251A (nl) 1985-05-17
SE8405338D0 (sv) 1984-10-25
HU190458B (en) 1986-09-29
DK508684A (da) 1985-04-26
FI76806C (fi) 1988-12-12
GB2148887A (en) 1985-06-05
IT8423305A0 (it) 1984-10-25
DE3439131A1 (de) 1985-05-02

Similar Documents

Publication Publication Date Title
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
AT384022B (de) Verfahren zur herstellung von 1,2,4-triazol-3onen
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
AT382381B (de) Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
ATA232384A (de) Verfahren zur herstellung neuer 1,5-benzothiazepine
ATA392384A (de) Verfahren zur herstellung neuer substituierter aminoguanidin-derivate
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
AT381104B (de) Verfahren zur herstellung neuer cyclopeptidderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
AT381490B (de) Verfahren zur herstellung neuer 3,3-dialkylund 3,3-alkylen-indolinderivate
AT387576B (de) Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
ATA260285A (de) Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate
AT387778B (de) Verfahren zur herstellung neuer 2h-azeto(2,1-a)isochinolin-derivate
ATA143885A (de) Verfahren zur herstellung neuer chinolinderivate
ATA259384A (de) Verfahren zur herstellung neuer 2,4-dimethyl-2 -hexenderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee